Nam W. Kim

Nam is a seasoned scientist and executive with over 25 years of experience in developing and commercializing novel diagnostics tests at several cutting-edge biotechnology companies including Geron, and diaDexus where he was responsible for the development of novel diagnostic and prognostic markers for cancer and cardiovascular diseases.